“…Numerous publications have successfully demonstrated that transcriptomics are suitable to distinguish genotoxic from non-genotoxic carcinogens (Lee et al, 2013;Magkoufopoulou, Claessen, Jennen, Kleinjans, & van Delft, 2011;Mathijs et al, 2009). Additional effort has been undertaken to use omics data to define specific biological functions or pathways which are connected to cellular responses to genotoxins, often using liver cells as a model system due to the need of metabolic activation of many genotoxic compounds: for example, deregulation of genes related to cell cycle and proliferation (Luckert, Hessel, Lenze, & Lampen, 2015;Rieswijk et al, 2016), apoptosis and cell death (Luckert et al, 2015;van Kesteren et al, 2011), and/or cellular and oxidative stress (Deferme, Wolters, Claessen, Briede, & Kleinjans, 2015;Smit, Souza, Jennen, Kleinjans, & van den Beucken, 2017) have been reported in vivo and in vitro.…”